TIL (Instil Bio, Inc. Common Stock) Stock Analysis - Politician Trades
Instil Bio, Inc. Common Stock (TIL) is a publicly traded Healthcare sector company. As of May 21, 2026, TIL trades at $8.02 with a market cap of $55.14M and a P/E ratio of -0.76. TIL moved +1.25% today. Year to date, TIL is -34.74%; over the trailing twelve months it is -51.22%. Its 52-week range spans $5.67 to $70.16. Rallies surfaces TIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TIL stock?
Rallies tracks politician and congressional stock disclosures for TIL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Laumas Sandeep sold 17.54K (~$404.10K) on Sep 10, 2025.
Laumas Sandeep sold 12.46K (~$297.57K) on Sep 10, 2025.
Vivo Capital IX, LLC bought 300.00K (~$6.00M) on Mar 23, 2021.
TIL Analyst Consensus
TIL analyst coverage data. Average price target: $0.00.
Common questions about TIL
Which politicians traded TIL stock?
Rallies tracks politician and congressional stock disclosures for TIL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in TIL?
Yes. Rallies tracks politician and congressional stock disclosures for TIL, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TIL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TIL. It does not provide personalized investment advice.